Media reports have been promoting ketamine as a fast and effective treatment for depression, partially due to the FDA’s approval of its cousin, esketamine. However, there are key differences between the two, including their chemical compositions, approved indications, and administration. The proliferation of ketamine clinics, particularly during the COVID-19 pandemic, has led to concerns about regulation and oversight. Additionally, there is a growing recreational use of ketamine, which has been linked to an increase in poisonings and potential risks. The medical community is calling for more data collection and stricter protocols to ensure the safe and responsible use of ketamine as a treatment for depression.
Source link
Ketamine vs Esketamine: Critical Differences Explained
